France· FR:65424737
BENEFIX 250 UI, poudre et solvant pour solution injectable
A nonacog alfa product containing nonacog alfa, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE). The same ATC class is registered in 3 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Nonacog alfa is registered in 3 of 19 countries.
Countries holding a registration under ATC Nonacog alfa (nonacog alfa), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 2 of them publish a price we can compare per daily dose
Nonacog alfa · ATC Nonacog alfa
3 / 19 countries
- Franceprice
- Spainprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- NONACOG ALFA
- Manufacturer
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Country
- France (FR)
- ATC code
- Nonacog alfa
- ATC class
- Nonacog alfa
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009571156231 flacon(s) en verre de 250 UI - 1 seringue(s) préremplie(s) en verre de 5 ml avec piston(s) avec adaptateur(s) pour flacon avec nécessaire(s) avec tampon(s) alcoolisé(s) avec pansement(s) et une compresse de gaze
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nonacog alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsBeneFIX 250 IE, poeder voor injectievloeistofPfizer Europe MA EEIG
- BelgiumBeneFIX 1000 IUPfizer Europe MA
- SwedenBeneFIX 1000 IE Pulver och vätska till injektionsvätska, lösningPfizer Europe MA EEIG
- CzechiaBENEFIXPfizer Europe MA EEIG, Bruxelles
- FinlandBenefixPfizer Europe MA EEIG
- IrelandBeneFIX 1000 IU powder and solvent for solution for injectionPfizer Europe MA EEIG
- IcelandBeneFIXPfizer Europe MA EEIG*
- PolandBeneFixPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Benefix, Rixubis
- Liechtenstein · Benefix, Rixubis
- Norway · Benefix, Rixubis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/331984d0-2f5f-42f7-b604-82d74aceb084 GET /v1/drugs/331984d0-2f5f-42f7-b604-82d74aceb084?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65424737",
"date_amm": "2007-07-30",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/97/047",
"substance": "NONACOG ALFA",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about nonacog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.